DERRICK BIRMINGHAM: Open Payments
NPI 1952336380 · BRONX, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$308 in 14 payments from 10 companies in 2025. Trend: 2023 $221 · 2024 $263 · 2025 $308
Food & beverage: $308
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $66 |
| Dexcom, Inc. | 2 | $44 |
| Merck Sharp & Dohme LLC | 2 | $42 |
| Astellas Pharma US Inc | 1 | $33 |
| GlaxoSmithKline, LLC. | 1 | $24 |
| Ardelyx, Inc. | 1 | $24 |
| Lilly USA, LLC | 1 | $21 |
| ViiV Healthcare Company | 1 | $20 |
| Medtronic, Inc. | 1 | $19 |
| Novartis Pharmaceuticals Corporation | 1 | $15 |
Products named: Ozempic, Dexcom G6 Transmitter, VERQUVO, Veozah, TRELEGY ELLIPTA, IBSRELA, MOUNJARO, APRETUDE.
Industry payments across NY — which companies pay providers there.
